Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 4/2011

Open Access 01-08-2011 | Research Article

Detection of viral DNA sequences in sporadic colorectal cancers in relation to CpG island methylation and methylator phenotype

Authors: Pawel Karpinski, Aleksander Myszka, David Ramsey, Wojciech Kielan, Maria Malgorzata Sasiadek

Published in: Tumor Biology | Issue 4/2011

Login to get access

Abstract

There is evidence that insertion of viral DNA into a mammalian genome can lead to alterations of methylation patterns. The aim of the present study was to examine the presence of DNA sequences of five human DNA viruses (assessed by PCR): JC polyoma virus (JCV), human adenovirus (AdV), Epstein–Barr virus (EBV), Kaposi sarcoma-associated herpesvirus (KSHV/HHV8) and human papillomavirus (HPV) in a cohort of 186 sporadic colorectal cancers (CRCs) and related these data with the methylation status of six CpG island methylator phenotype (CIMP)-specific genes (MLH1, CACNA1G, NEUROG1, IGF2, SOCS1, RUNX3) and seven cancer-related genes markers (p16, MINT1, MINT2, MINT31, EN1, SCTR and INHBB) assessed by methylation-specific PCR in 186 and 134 CRC cases, respectively. The AdV, KSHV and HPV were detected in four (2%), two (1%) and zero CRC cases, respectively, and thus were excluded from further analyses. Although 19% and 9% of the CRCs were positive for EBV and JCV, respectively, no associations between virus presence and CpG island methylation were found after correction for multiple testing. Our results demonstrate that the presence of DNA sequences of JCV and EBV in CRC is unrelated to the methylation of the 13 cancer-related CpG islands and CIMP.
Literature
1.
2.
Karpinski P, Sasiadek MM, Blin N. Aberrant epigenetic patterns in the etiology of gastrointestinal cancers. J Appl Genet. 2008;49:1–10.PubMedCrossRef
3.
Weisenberger DJ, Siegmund KD, Campan M, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet. 2006;38:787–93.PubMedCrossRef
4.
5.
Doerfler W. Epigenetic mechanisms in human adenovirus type 12 oncogenesis. Semin Cancer Biol. 2009;19:136–43.PubMedCrossRef
6.
Brennan EP, Ehrich M, Brazil DP, et al. Comparative analysis of DNA methylation profiles in peripheral blood leukocytes versus lymphoblastoid cell lines. Epigenetics. 2009;3:159–64.CrossRef
7.
Grafodatskaya D, Choufani S, Ferreira JC, Butcher DT, Lou Y, Zhao C, et al. EBV transformation and cell culturing destabilizes DNA methylation in human lymphoblastoid cell lines. Genomics. 2010;2:73–83.CrossRef
8.
Flanagan JM. Host epigenetic modifications by oncogenic viruses. Br J Cancer. 2007;29:183–8.CrossRef
9.
Horwitz GA, Zhang K, McBrian MA, Grunstein M, Kurdistani SK, Berk AJ. Adenovirus small e1a alters global patterns of histone modification. Science. 2008;22:1084–5.CrossRef
10.
Zimmermann H, Degenkolbe R, Bernard HU, O’Connor MJ. The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. J Virol. 1999;73:6209–19.PubMed
11.
Shamay M, Krithivas A, Zhang J, Hayward SD. Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi’s sarcoma-associated herpesvirus LANA. PNAS. 2006;26:14554–9.CrossRef
12.
Tsai CL, Li HP, Lu YJ, et al. Activation of DNA methyltransferase 1 by EBV LMP1 involves c-Jun NH2-terminal kinase signaling. Cancer Res. 2006;15:11668–76.CrossRef
13.
Goel A, Li MS, Nagasaka T, Shin SK, Fuerst F, Ricciardiello L, et al. Association of JC virus T-antigen expression with the methylator phenotype in sporadic colorectal cancers. Gastroenterology. 2006;130:1950–61.PubMedCrossRef
14.
Sapio MR, Posca D, Troncone G, Pettinato G, Palombini L, Rossi G, et al. Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA). Eur J Endocrinol. 2006;154:341–8.PubMedCrossRef
15.
Chan A, Issa JP, Morris JS, Hamilton SR, Rashid A. Concordant CpG island methylation in hyperplastic polyposis. Am J Pathol. 2002;160:529–36.PubMedCrossRef
16.
Karpinski P, Ramsey D, Grzebieniak Z, Sasiadek MM, Blin N. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer. Mol Cancer Res. 2008;6:585–91.PubMedCrossRef
17.
Pan L, Milligan L, Michaeli J, Cesarman E, Knowles DM. Polymerase chain reaction detection of Kaposi’s sarcoma-associated herpesvirus-optimized protocols and their application to myeloma. J Mol Diagn. 2001;3:32–8.PubMedCrossRef
18.
Fujinaga Y, Shimada M, Okazawa K, Fukushima M, Kato I, Fujinaga K. Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J Gen Virol. 1991;72:1039–44.PubMedCrossRef
19.
Echavarria M, Forman M, Ticehurst J, Dumler JS, Charache P. PCR method for detection of adenovirus in urine of healthy and human immunodeficiency virus-infected individuals. J Clin Microbiol. 1998;36:3323–6.PubMed
20.
Schuebel KE, Chen W, Cope L, et al. Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet. 2007;3:1709–23.PubMedCrossRef
21.
Müller K, Heller H, Doerfler W. Foreign DNA integration. Genome-wide perturbations of methylation and transcription in the recipient genomes. J Biol Chem. 2001;27:14271–8.
22.
Knösel T, Schewe C, Petersen N, Dietel M, Petersen I. Prevalence of infectious pathogens in Crohn’s disease. Pathol Res Pract. 2009;205:223–30.PubMedCrossRef
23.
Cheng JY, Sheu LF, Meng CL, Lee WH, Lin JC. Detection of human papillomavirus DNA in colorectal carcinomas by polymerase chain reaction. Gut. 1995;37:87–90.PubMedCrossRef
24.
Bodaghi S, Yamanegi K, Xiao SY, Da Costa M, Palefsky JM, Zheng ZM. Colorectal papillomavirus infection in patients with colorectal cancer. Clin Cancer Res. 2005;11:2862–7.PubMedCrossRef
25.
Damin DC, Caetano MB, Rosito MA, Schwartsmann G, Damin AS, Frazzon AP, et al. Evidence for an association of human papillomavirus infection and colorectal cancer. Eur J Surg Oncol. 2007;33:569–74.PubMed
26.
Atula S, Grenman R, Kujari H, Syrjänen S. Detection of human papillomavirus (HPV) in laryngeal carcinoma cell lines provides evidence for a heterogeneic cell population. Eur J Cancer. 1999;5:825–32.CrossRef
27.
Cho YJ, Chang MS, Park SH, Kim HS, Kim WH. In situ hybridization of Epstein–Barr virus in tumor cells and tumor-infiltrating lymphocytes of the gastrointestinal tract. Hum Pathol. 2001;32:297–301.PubMedCrossRef
28.
Kijima Y, Hokita S, Takao S, et al. Epstein–Barr virus involvement is mainly restricted to lymphoepithelial type of gastric carcinoma among various epithelial neoplasms. J Med Virol. 2001;4:513–8.CrossRef
29.
Liu HX, Ding YQ, Li X, Yao KT. Investigation of Epstein–Barr virus in Chinese colorectal tumors. World J Gastroenterol. 2003;9:2464–8.PubMed
30.
Bonnet M, Guinebretiere J-M, Kremmer E, Grunewald V, Benhamou E, Contesso G, et al. Detection of Epstein–Barr virus in invasive breast cancers. J Natl Cancer Inst. 1999;91:1376–81.PubMedCrossRef
31.
Sugawara Y, Mizugaki Y, Uchida T, Torii T, Imai S, Makuuchi M, et al. Detection of Epstein–Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression. Virology. 1999;256:196–202.PubMedCrossRef
32.
Yoshiyama H, Imai S, Shimizu N, Takada K. Epstein–Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21. J Virol. 1997;7:5688–91.
33.
Shannon-Lowe CD, Neuhierl B, Baldwin G, Rickinson AB, Delecluse HJ. Resting B cells as a transfer vehicle for Epstein–Barr virus infection of epithelial cells. PNAS. 2006;18:7065–70.CrossRef
34.
Hernández Losa J, Fernandez-Soria V, Parada C, Sanchez-Prieto R, Ramón Y, Cajal S, et al. JC virus and human colon carcinoma: an intriguing and inconclusive association. Gastroenterology. 2003;1:268–9.CrossRef
35.
Hori R, Murai Y, Tsuneyama K, et al. Detection of JC virus DNA sequences in colorectal cancers in Japan. Virchows Arch. 2005;4:723–30.CrossRef
36.
Giuliani L, Ronci C, Bonifacio D, Di Bonito L, Favalli C, Perno CF, et al. Detection of oncogenic DNA viruses in colorectal cancer. Anticancer Res. 2008;28(2B):1405–10.PubMed
37.
Burnett-Hartman AN, Newcomb PA, Potter JD. Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus. Cancer Epidemiol Biomarkers Prev. 2008;17:2970–9.PubMedCrossRef
38.
Nosho K, Shima K, Kure S, et al. JC virus T-antigen in colorectal cancer is associated with p53 expression and chromosomal instability, independent of CpG island methylator phenotype. Neoplasia. 2009;11:87–95.PubMed
39.
Ricciardiello L, Baglioni M, Giovannini C, et al. Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus. Cancer Res. 2003;63:7256–62.PubMed
40.
Del Valle L, Khalili K. Detection of human polyomavirus proteins, T-antigen and agnoprotein, in human tumor tissue arrays. J Med Virol. 2010;5:806–11.CrossRef
41.
Cheng YW, Pincas H, Bacolod MD, et al. CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer. Clin Cancer Res. 2008;14:6005–13.PubMedCrossRef
Metadata
Title
Detection of viral DNA sequences in sporadic colorectal cancers in relation to CpG island methylation and methylator phenotype
Authors
Pawel Karpinski
Aleksander Myszka
David Ramsey
Wojciech Kielan
Maria Malgorzata Sasiadek
Publication date
01-08-2011
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 4/2011
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-011-0165-6

Other articles of this Issue 4/2011

Tumor Biology 4/2011 Go to the issue

Research Article

Cytostatic effect of novel mTOR inhibitor, PRP-1 (galarmin) in MDA 231 (ER−) breast carcinoma cell line. PRP-1 inhibits mesenchymal tumors

Research Article

Ezrin mRNA target site selection for DNAzymes using secondary structure and hybridization thermodynamics

Research Article

Prognostic factors and survival in patients with neuroendocrine tumors of the pancreas

Research Article

Zinc induces cell cycle arrest and apoptosis by upregulation of WIG-1 in esophageal squamous cancer cell line EC109

Research Article

Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer

Research Article

Klotho, an anti-senescence related gene, is frequently inactivated through promoter hypermethylation in colorectal cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits